Biofrontera (BFRI) EBITDA Margin (2020 - 2026)
Biofrontera (BFRI) reported EBITDA Margin of -4.37% for Q2 2026, up 51.84 percentage points from -56.20% a year earlier.
Powered by 
Analysis
Biofrontera (BFRI) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biofrontera's EBITDA Margin came in at -15.99%, up 25.08 percentage points year-over-year; for FY2025, it came in at -26.88%, up 17.22 percentage points from FY2024.
- EBITDA Margin has a five-year change of +21.10 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -44.10% in FY2024 (+19.47 pp), -63.57% in FY2023 (-0.58 pp), -62.99% in FY2022 (+39.34 pp) and -102.33% in FY2021 (-54.35 pp).
- Five-year quarterly EBITDA Margin spans a low of -368.62% in Q3 2021 and a high of 26.87% in Q4 2025.
- Year over year, EBITDA Margin gained in five of the last seven quarters, with an average year-over-year change of +13.93 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q3 2022 (a gain of 287.34 percentage points); the low point was Q3 2021 (a drop of 297.65 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Biofrontera | 16.05 Mn | -5.74 Mn | 9.59 Mn | -4.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.37% |
| Dec 31, 2025 | 26.87% |
| Sep 30, 2025 | -88.87% |
| Jun 30, 2025 | -56.20% |
| Mar 31, 2025 | -52.61% |
| Dec 31, 2024 | -13.30% |
| Sep 30, 2024 | -53.61% |
| Jun 30, 2024 | -63.15% |
| Mar 31, 2024 | -67.48% |
| Dec 31, 2023 | -35.30% |
| Sep 30, 2023 | -50.57% |
| Jun 30, 2023 | -146.67% |
| Mar 31, 2023 | -61.43% |
| Dec 31, 2022 | -53.79% |
| Sep 30, 2022 | -81.28% |
| Jun 30, 2022 | -136.46% |
| Mar 31, 2022 | -30.55% |
| Dec 31, 2021 | -19.13% |
| Sep 30, 2021 | -368.62% |
| Jun 30, 2021 | -60.63% |
API Access
Biofrontera EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();